▪️Fambrini DL, Campos Neto EL, Ferreira Dos Santos C. Acute Effect of Oral Adenosine Triphosphate (ATP) Supplementation on Muscular Performance in Trained Adults. J Am Nutr Assoc. 2024 Jul;43(5):412-420.
▪️Freitas MC, Cholewa JM, Gerosa-Neto J, Gonçalves DC, Caperuto EC, Lira FS, Rossi FE. A Single Dose of Oral ATP Supplementation Improves Performance and Physiological Response During Lower Body Resistance Exercise in Recreational Resistance-Trained Males. J Strength Cond Res. 2019 Dec;33(12):3345-3352.
▪️González-Marenco R, Estrada-Sánchez IA, Medina-Escobedo M, Chim-Aké R, Lugo R. The Effect of Oral Adenosine Triphosphate (ATP) Supplementation on Anaerobic Exercise in Healthy Resistance-Trained Individuals: A Systematic Review and Meta-Analysis. Sports (Basel). 2024 Mar 14;12(3):82.
▪️Moon JM, Dufner TJ, Wells AJ. Evaluating the effects of PeakATP® supplementation on visuomotor reaction time and cognitive function following high-intensity sprint exercise. Front Nutr. 2023 Aug 4;10:1237678.
▪️Purpura M, Rathmacher JA, Sharp MH, Lowery RP, Shields KA, Partl JM, Wilson JM, Jäger R. Oral Adenosine-5'-triphosphate (ATP) Administration Increases Postexercise ATP Levels, Muscle Excitability, and Athletic Performance Following a Repeated Sprint Bout. J Am Coll Nutr. 2017 Mar-Apr;36(3):177-183.
▪️Rathmacher JA, Fuller JC Jr, Baier SM, Abumrad NN, Angus HF, Sharp RL. Adenosine-5'-triphosphate (ATP) supplementation improves low peak muscle torque and torque fatigue during repeated high intensity exercise sets. J Int Soc Sports Nutr. 2012 Oct 9;9(1):48.
▪️TSI Group. TSI Group Granted GRAS Status for PEAK ATP. Nutraceuticals World. 2015. Disponible en: https://www.nutraceuticalsworld.com/breaking-news/tsi-group-granted-gras-status-for-peak-atp/
▪️Wilson JM, Joy JM, Lowery RP, Roberts MD, Lockwood CM, Manninen AH, Fuller JC, De Souza EO, Baier SM, Wilson SM, Rathmacher JA. Effects of oral adenosine-5'-triphosphate supplementation on athletic performance, skeletal muscle hypertrophy and recovery in resistance-trained men. Nutr Metab (Lond). 2013 Sep 22;10(1):57.